ITK and B-cell chronic lymphocytic leukemia: These data suggest that while inhibiting ITK during CAR-T cell production can temporarily alleviate exhaustion and promote memory phenotype in CLL-CAR-T cells in vitro, genetic targeting or continuous pharmacological inhibition of T cell–intrinsic ITK signaling is probably required to sustain the long-term responses of CAR-T cells against tumors.